Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Helin Wang; Qi Lu; Yifan Miao; Jiaxuan Song; Mingyang Zhang; Haotian Zhang; Zhonggui He; Zixuan Wang; Chutong Tian; Jin Sun

doi:10.1007/s12274-022-5257-7

Nano Research 2023, 16(4): 6010-6011 https://doi.org/10.1007/s12274-022-5257-7

Erratum | Issue | Published: 18 November 2022

Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Show Author's Information Hide Author's Information Helin Wang^{¹^,^§}, Qi Lu^{¹^,^§}, Yifan Miao^¹, Jiaxuan Song^¹, Mingyang Zhang^¹, Zixuan Wang^¹, Haotian Zhang^², Zhonggui He^¹, Chutong Tian^¹(

), Jin Sun^¹(

)

1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China

2School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China

^§ Helin Wang and Qi Lu contributed equally to this work.

Keywords:

ascorbic acid, oral chemotherapy, structured lipid-mimetic prodrug, 7-ethyl-10-hydroxycamptothecin (SN38)

The online version of the original article can be found at https://doi.org/10.1007/s12274-022-4544-7

Cite this article:

Wang H, Lu Q, Miao Y, et al. Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid. Nano Research, 2023, 16(4): 6010-6011. https://doi.org/10.1007/s12274-022-5257-7

Download citation

EndNote(RIS)

BibTeX

340

Views

Downloads

Citations

Crossref

WoS

Scopus

CSCD

Full text About this article

Full text

Outline

About this article

Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Show Author's information Hide Author's Information Helin Wang^{¹^,^§}, Qi Lu^{¹^,^§}, Yifan Miao^¹, Jiaxuan Song^¹, Mingyang Zhang^¹, Zixuan Wang^¹, Haotian Zhang^², Zhonggui He^¹, Chutong Tian^¹(

), Jin Sun^¹(

)

1Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China

2School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China

^§ Helin Wang and Qi Lu contributed equally to this work.

Keywords: ascorbic acid, oral chemotherapy, structured lipid-mimetic prodrug, 7-ethyl-10-hydroxycamptothecin (SN38)

About this article

Publication history

Published: 18 November 2022

Issue date: April 2023

Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Publication history

Copyright